Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Many Hospitals Noncompliant With Record Request Regulations
MONDAY, Oct. 29, 2018 (HealthDay News) — Among top-ranked U.S. hospitals, data reveal discrepancies in information provided to patients regarding medical records release processes as well as noncompliance with state and federal regulations, according to a study published online Oct. 5 in JAMA Network Open.
Cancer Survival Higher in Teens, Young Adults Than Other Groups
FRIDAY, Oct. 26, 2018 (HealthDay News) — Overall, cancer survival among adolescents and young adults (AYAs) has consistently exceeded that of other age groups except during the HIV/AIDS epidemic, according to a study published Oct. 15 in the Journal of the National Cancer Institute.
Abstract/Full Text (subscription or payment may be required)
Trump Administration Announces Plan to Cut Drug Prices
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
HHS Study
New York Times Article
High-Coverage Rollout of PReP Tied to Drop in HIV Diagnoses
FRIDAY, Oct. 26, 2018 (HealthDay News) — A rapid, targeted, high-coverage rollout of HIV pre-exposure prophylaxis (PrEP) is associated with a decrease in HIV diagnoses among high-risk men who have sex with men (MSM), according to a study published online Oct. 17 in The Lancet.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Infant HIV Infection Ups Risk for Congenital CMV Infection
THURSDAY, Oct. 25, 2018 (HealthDay News) — HIV-exposed infants have high rates of congenital cytomegalovirus (cCMV) infection, and in utero HIV infection seems to be a major risk factor for cCMV, according to a study published in the October issue of The Pediatric Infectious Disease Journal.
Abstract/Full Text (subscription or payment may be required)
Pace of Change Has Accelerated in Alternative Payment Models
THURSDAY, Oct. 25, 2018 (HealthDay News) — The impact of alternative payment models (APMs) on physician practices has been described in a study published by the RAND Corp. and the American Medical Association.
Most Supplements Contain Prohibited Stimulants
FDA Could Ease Blood Donation Rules for Gay Men 
Another Significant HIV Vaccine Trial Fails 
Women Experiencing Intimate Partner Violence More Likely to Contract HIV 
Cognitive Behavioral Intervention Ups ART Adherence in Adolescents, Young Adults 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
.jpg)